Objects
Denham, J. W., Steigler, A., Smithers, B. M., Ackland, S., Walpole, E., Kilmurray, J., Wratten, C., Burmeister, B., Lam, D. S., Joseph, D., Delaney, G., Christie, D., Jamieson, G.. The Royal College of Radiologists / Elsevier Science Ltd.; 2003. Relapse patterns after chemo-radiation for carcinoma of the oesophagus.
Guo, S. T., Chi, M. N., Yan, X. G., Farrelly, M., Wang, F. H., Lai, F., Wang, J. F., Li, Y. P., Ackland, S., Scott, R., Agoulnik, I. U., Hondermarck, H., Yang, R. H., Thorne, R. F., Liu, T., Zhang, X. D., Jiang, C. C., Guo, X. Y., Zan, L. K., Wang, C. Y., Xi, Y. F., Jin, L., Croft, A., Tseng, H.-Y.. Nature Publishing Group; 2016. INPP4B is an oncogenic regulator in human colon cancer.
Mercieca-Bebber, R., Barnes, E. H., Leung, J., Wang, T., Bohmer, R., Cameron, D., Simes, J., Gebski, V., Smithers, M., Thomas, J., Zalcberg, J., Barbour, A. P., Wilson, K., Samoon, Z., Walpole, E., Mai, T., Ackland, S., Burge, M., Dickie, G., Watson, D.. BioMed Central (BMC); 2022. Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma.